Credo Technology Group’s share price retracement in late 2025 reflects a contraction in valuation multiples rather than any deterioration in underlying fundamentals. After logging a 110% gain for the calendar year—and peaking up more than 200% in early December—the stock saw its enterprise-value-to-sales multiple fall from roughly 15× to near 10×. Revenue guidance for fiscal 2026 remains unchanged at $165 million to $175 million, and gross margins are still expected to expand by 200 basis points. The multiple contraction presents a lower entry point for investors seeking exposure to high-growth optical interconnects without sacrificing revenue momentum.

Credo’s proprietary ZeroFlap optics technology, which enables real-time monitoring of link health and reduces packet loss by up to 70%, is positioned as a key growth catalyst through 2027. This innovation addresses a critical reliability challenge in large-scale AI deployments, where even brief link failures can trigger costly retraining cycles. Beta customers have reported a 40% reduction in unplanned downtime during initial trials, and Credo has secured commitments from two hyperscale data center operators for production shipments in the second half of 2026. Continued ramp of ZeroFlap is forecast to contribute more than 30% of total revenues by year-end.

Beyond hyperscale AI, Credo is broadening its addressable market through new design wins in enterprise storage, high-performance computing and telecom switch interconnects. The company’s scheduled launch of a PCIe Gen6 retimer solution in mid-2026 opens a path into server motherboard segments with aggregate annual demand exceeding $500 million. Early adopter OEMs include two leading blade-server manufacturers, which are expected to generate initial revenues in the fourth quarter. Management projects that non-AI end markets will account for 25% of total sales by fiscal 2027, reducing revenue concentration and supporting sustained high-margin growth.

Credo’s story has attracted increasing interest from institutional investors, with 12% of shares outstanding now held by dedicated semiconductor funds—up from 7% at the start of 2025. Research houses have nine buy or outperform ratings versus just two hold recommendations. Consensus revenue estimates for fiscal 2027 stand at $225 million, representing a 30% compound annual growth rate over three years. With gross margins projected near 52% and operating leverage set to drive profitability, the stock’s current valuation offers a compelling risk-reward profile for those positioning portfolios for the ongoing AI infrastructure build-out.